Clinical Trials Browser

Ototoxicity × sodium thiosulfate × Clear all

NCT05756660 2025-10-20

Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

Phase EARLY_PHASE1 Suspended

Gastrointestinal

Ototoxicity, Neoplasms, Germ Cell and Embryonal, Hepatoblastoma

NCT04262336 2023-07-06

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Phase 1 Completed

Ototoxicity, Hearing Loss

NCT00652132 2018-05-29

SIOPEL6

Phase 3 Completed

116 enrolled 1 FDA

Gastrointestinal

Ototoxicity, Liver Neoplasms, Hepatoblastoma